Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL
Gordon, Kenneth, MD, Papp, Kim, MD, PhD, Poulin, Yves, MD, Gu, Yihua, MS, Rozzo, Stephen, PhD, Sasso, Eric H., MD
Published in Journal of the American Academy of Dermatology (01.02.2012)
Published in Journal of the American Academy of Dermatology (01.02.2012)
Get full text
Journal Article